Abe Heifets

July 23, 2019

What’s Your Moonshot? Abraham Heifets of Atomwise Is Using AI to Speed up the Development of Medications Targeted at Specific Cancer Cells

In The News

Noah Miller of Newsweek interviews Abraham Heifets, Atomwise CEO, about his Moonshot.

Read Article

June 4, 2019

Time For AI To Deliver In Drug Discovery, Says Atomwise CEO

In The News

Having signed a multi-year, multi-target agreement with Lilly worth potentially $550m, Atomwise CEO Abe Heifets tells Scrip the burden of proof is on AI practitioners to start producing relevant and actionable data.

Read Article

Events

Oct 25-29, 2020

BIO-Europe

Digital Conference
Nov 6, 2020

AUTM Webinar

Virtual Webinar
Dec 2-4, 2020

Web Summit 2020

Virtual Conference

Publications

August 18, 2020

Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

Arash Keshavarzi Arshadi, Julia Webb, Milad Salem, Emmanuel Cruz, Stacie Callad-Thomson, Niloofar Ghadirian, Jennifer Collins, Elen Diez-Cecilia, Brendan Kelly, Hani Goodarzi, and Jiann Shiun Yuan
August 17, 2020

Current methods and challenges for deep learning in drug discovery

Stefan Schroedl
July 30, 2020

Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network

Adrian Stecula, Muhammad S. Hussain, Ronald E. Viola
July 30, 2020

Small molecules block the interaction between porcine reproductive and respiratory syndrome virus and CD163 receptor and the infection of pig cells

Chang Huang, Denzil Bernard, Jiaqi Zhu, Radha Charan Dash, Alexander Chu, Alec Knupp, Anna Hakey, M. Kyle Hadden, Antonio Garmendia, Young Tang
September 26, 2019

Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models

Chung-Han Hsieh, Li Li, Roeland Vanhauwaert, Kong T. Nguyen, Mary D. Davis, Guojun Bu, Zbigniew K. Wszolek, Xinnan Wang